Abstract
The driver mutations in exon 9 of the calreticulin protein have only been identified in patients with myeloid cancers. We recently demonstrated that healthy individuals display strong and frequent T-cell responses towards this mutation. This memory T-cell response is likely evidence of the elimination of mutated cells in healthy individuals.
Original language | English |
---|---|
Article number | 1599640 |
Journal | OncoImmunology |
Volume | 8 |
Issue number | 7 |
Number of pages | 2 |
ISSN | 2162-4011 |
DOIs | |
Publication status | Published - 2019 |
Keywords
- calreticulin
- cancer immunoediting
- hematological cancer
- memory T-cells
- Neoantigens